retatrutide approval status eli lilly VisualAbstract: reduces body weight by 17.5% in patients with obesity Eli Lilly's Retatrutide Delivers Bariatric-Style

Decreasing incidence of thyrotoxicosis in an endemic goitre inland area of Sweden

For the first 3 weeks I was becoming skeptical by the day and then WHAM

Patients should: Stay well hydrated Eat smaller, more frequent meals Avoid high-fat, greasy, or very spicy foods if experiencing nausea Report persistent or severe symptoms to their prescriber When to seek medical advice: Contact your GP or diabetes team for: Persistent vomiting or diarrhoea Concerns about medication effects or side effects Symptoms of hypoglycaemia if taking other diabetes medications Contact NHS 111 or seek urgent care for: Severe, persistent vomiting preventing fluid intake Signs of dehydration (dark urine, dizziness, reduced urination) Severe or persistent abdominal pain, particularly if radiating to the back (potential pancreatitis) Pain in the right upper abdomen, yellowing of skin/eyes (potential gallbladder issues) Sudden vision changes Allergic reactions (rash, difficulty breathing, facial swelling) Most patients find that side effects diminish significantly after 812 weeks, and the benefits of appetite control and metabolic improvement become more apparent

Its important to note that GLP-2, a hormone involved in intestinal growth, is not targeted by either of these medications

This product is intended forLaboratory Research Use Only